DHX9 sustains hematopoietic stem cell function in cooperation with H3 acetylation.

Area of Science:

• Hematology
• Molecular Biology
• Epigenetics

Background:

• Hematopoietic stem cells (HSCs) are crucial for blood cell production and are regulated by complex epigenetic and transcriptional networks.
• Maintaining HSC function is vital for preventing bone marrow failure.

Purpose of the Study:

• To identify key regulators of HSC maintenance.
• To elucidate the molecular mechanisms underlying HSC regulation by DHX9.

Main Methods:

• Gene deletion studies in murine models.
• Hematopoietic stem cell transplantation assays.
• Analysis of cell cycle, apoptosis, and reactive oxygen species (ROS).
• Chromatin immunoprecipitation and gene expression analysis.

Main Results:

• DHX9 deletion in mice led to bone marrow failure and impaired HSC self-renewal.
• DHX9 deficiency resulted in increased apoptosis, cell cycle abnormalities, and elevated ROS.
• DHX9 interacts with CBP/p300 to maintain H3 acetylation at hematopoietic gene promoters.
• Enhancing H3K27ac partially rescued hematopoietic defects in mouse models and human CD34+ cells.

Conclusions:

• DHX9 is a critical regulator of HSC maintenance and function.
• DHX9 links epigenetic modifications (H3 acetylation) with transcriptional programs essential for hematopoiesis.
• Targeting DHX9 or related epigenetic pathways may offer therapeutic strategies for bone marrow failure syndromes.